News
OPRX
12.48
-2.19%
-0.28
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story
Seeking Alpha · 5d ago
Lake Street Reaffirms Their Buy Rating on OptimizeRx (OPRX)
TipRanks · 5d ago
OptimizeRx Chief Finance & Strategy Officer Edward Stelmakh Reports Disposal of Common Shares
Reuters · 6d ago
Weekly Report: what happened at OPRX last week (1215-1219)?
Weekly Report · 6d ago
OptimizeRx (OPRX) Gets a Buy from Lake Street
TipRanks · 12/17 13:55
OptimizeRx announces four new partner agreements
TipRanks · 12/17 10:15
OptimizeRx Announced Four New Partner Agreements That Expand Its In-Workflow Point-of-care Network, Fortify Its Long-term Competitive Position, And Increase Total National Provider Identifier Reach, Deal Terms Were Undisclosed
Benzinga · 12/17 09:33
OptimizeRx Secures Exclusive Multi-Year Partnerships to Expand Point-of-Care Network
Reuters · 12/17 09:30
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
Barchart · 12/17 03:30
Weekly Report: what happened at OPRX last week (1208-1212)?
Weekly Report · 12/15 09:51
Halozyme Therapeutics Elects Jim Lang to Board of Directors
Reuters · 12/08 21:05
Weekly Report: what happened at OPRX last week (1201-1205)?
Weekly Report · 12/08 09:51
Top SA Quant rated small-cap stocks as Russell 2000 notches a record close
Seeking Alpha · 12/04 21:38
Weekly Report: what happened at OPRX last week (1124-1128)?
Weekly Report · 12/01 09:48
Weekly Report: what happened at OPRX last week (1117-1121)?
Weekly Report · 11/24 09:51
Whetstone Sells All Freshworks Shares
NASDAQ · 11/23 14:54
OptimizeRx Unveils Presentation Showcasing Technology Solutions for Patient Engagement and Pharma Connectivity
Reuters · 11/18 18:59
Stifel Nicolaus Remains a Buy on OptimizeRx (OPRX)
TipRanks · 11/18 17:36
OptimizeRx Is Maintained at Equal-Weight by Stephens & Co.
Dow Jones · 11/17 13:05
OptimizeRx Price Target Cut to $17.00/Share From $20.00 by Stephens & Co.
Dow Jones · 11/17 13:05
More
Webull provides a variety of real-time OPRX stock news. You can receive the latest news about Optimizerx Corp through multiple platforms. This information may help you make smarter investment decisions.
About OPRX
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.